Select Publications

Journal articles

Thompson J; Amin A; Stricker P, 2020, 'Magnetic Resonance Imaging Improves Selection for Active Surveillance and Can Extend the Interval Between Biopsies', European Urology, vol. 78, pp. 518 - 519, http://dx.doi.org/10.1016/j.eururo.2020.07.001

Amin A; Scheltema MJ; Shnier R; Blazevski A; Moses D; Cusick T; Siriwardena A; Yuen B; van Leeuwen PJ; Haynes AM; Matthews J; Brenner P; O'Neill G; Yuen C; Delprado W; Stricker P; Thompson J, 2020, 'Reply by Authors', The Journal of urology, vol. 204, pp. 843 - 844, http://dx.doi.org/10.1097/JU.0000000000001191

Thompson JE; Stricker PD, 2020, 'Editorial Comment', The Journal of urology, vol. 204, pp. 495, http://dx.doi.org/10.1097/JU.0000000000000811.01

Algohary A; Shiradkar R; Pahwa S; Purysko A; Verma S; Moses D; Shnier R; Haynes AM; Delprado W; Thompson J; Tirumani S; Mahran A; Rastinehad AR; Ponsky L; Stricker PD; Madabhushi A, 2020, 'Combination of peri-tumoral and intra-tumoral radiomic features on bi-parametric mri accurately stratifies prostate cancer risk: A multi-site study', Cancers, vol. 12, pp. 1 - 14, http://dx.doi.org/10.3390/cancers12082200

Emmett L; Tang R; Nandurkar R; Hruby G; Roach P; Watts JA; Cusick T; Kneebone A; Ho B; Chan L; van Leeuwen PJ; Scheltema MJ; Nguyen A; Yin C; Scott A; Tang C; McCarthy M; Fullard K; Roberts M; Francis R; Stricker P, 2020, '3-Year Freedom from Progression After 68Ga-PSMA PET/CT-Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter Trial', Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol. 61, pp. 866 - 872, http://dx.doi.org/10.2967/jnumed.119.235028

Miladinovic D; Cusick T; Mahon KL; Haynes AM; Cortie CH; Meyer BJ; Stricker PD; Wittert GA; Butler LM; Horvath LG; Hoy AJ, 2020, 'Assessment of periprostatic and subcutaneous adipose tissue lipolysis and adipocyte size from men with localized prostate cancer', Cancers, vol. 12, http://dx.doi.org/10.3390/cancers12061385

Huits TH; Luiting HB; van der Poel HG; Nandurkar R; Donswijk M; Schaake E; Vogel W; Roobol MJ; Wit E; Stricker P; Emmett L; van Leeuwen PJ, 2020, 'Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (68Ga-PSMA) positron-emission/computed tomography after radical prostatectomy with pathological node-positive extended lymph node dissection', BJU International, vol. 125, pp. 876 - 883, http://dx.doi.org/10.1111/bju.15052

Blazevski A; Scheltema MJ; Yuen B; Masand N; Nguyen TV; Delprado W; Shnier R; Haynes AM; Cusick T; Thompson J; Stricker P, 2020, 'Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort', European urology oncology, vol. 3, pp. 283 - 290, http://dx.doi.org/10.1016/j.euo.2019.04.008

Crumbaker M; Chan EKF; Gong T; Corcoran N; Jaratlerdsiri W; Lyons RJ; Haynes AM; Kulidjian AA; Kalsbeek AMF; Petersen DC; Stricker PD; Jamieson CAM; Croucher PI; Hovens CM; Joshua AM; Hayes VM, 2020, 'The impact of whole genome data on therapeutic decision‐making in metastatic prostate cancer: A retrospective analysis', Cancers, vol. 12, http://dx.doi.org/10.3390/cancers12051178

Amin A; Scheltema MJ; Shnier R; Blazevski A; Moses D; Cusick T; Siriwardena A; Yuen B; van Leeuwen PJ; Haynes AM; Matthews J; Brenner P; O'Neill G; Yuen C; Delprado W; Stricker P; Thompson J, 2020, 'The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies', The Journal of urology, vol. 203, pp. 910 - 917, http://dx.doi.org/10.1097/JU.0000000000000693

Amin A; Blazevski A; Thompson J; Scheltema MJ; Hofman MS; Murphy D; Lawrentschuk N; Sathianathen N; Kapoor J; Woo HH; Chalasani V; Rasiah K; van Leeuwen PJ; Tang R; Cusick T; Stricker P; Emmett L, 2020, 'Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer', BJU International, vol. 125, pp. 515 - 524, http://dx.doi.org/10.1111/bju.14999

Blazevski A; Scheltema MJ; Amin A; Thompson JE; Lawrentschuk N; Stricker PD, 2020, 'Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment', BJU International, vol. 125, pp. 369 - 378, http://dx.doi.org/10.1111/bju.14951

Luiting HB; van Leeuwen PJ; Busstra MB; Brabander T; van der Poel HG; Donswijk ML; Vis AN; Emmett L; Stricker PD; Roobol MJ, 2020, 'Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature', BJU International, vol. 125, pp. 206 - 214, http://dx.doi.org/10.1111/bju.14944

Scheinberg T; Kench J; Stockler M; Mahon KL; Sebastian L; Stricker P; Joshua AM; Woo H; Thanigasalam R; Ahmadi N; Centenera MM; Butler LM; Horvath LG, 2020, 'Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: A study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer)', BMJ Open, vol. 10, http://dx.doi.org/10.1136/bmjopen-2019-033667

Blazevski A; Amin A; Scheltema MJ; Balakrishnan A; Haynes AM; Barreto D; Cusick T; Thompson J; Stricker PD, 2020, 'Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE)', World Journal of Urology, http://dx.doi.org/10.1007/s00345-020-03275-z

Amin A; Blazevski A; Scheltema M; Stricker P, 2020, 'Transperineal biopsy of the prostate in a patient post abdominoperineal resection', Urology Case Reports, vol. 28, http://dx.doi.org/10.1016/j.eucr.2019.101055

Lam TBL; MacLennan S; Willemse PPM; Mason MD; Plass K; Shepherd R; Baanders R; Bangma CH; Bjartell A; Bossi A; Briers E; Briganti A; Buddingh KT; Catto JWF; Colecchia M; Cox BW; Cumberbatch MG; Davies J; Davis NF; De Santis M; Dell'Oglio P; Deschamps A; Donaldson JF; Egawa S; Fankhauser CD; Fanti S; Fossati N; Gandaglia G; Gillessen S; Grivas N; Gross T; Grummet JP; Henry AM; Ingels A; Irani J; Lardas M; Liew M; Lin DW; Moris L; Omar MI; Pang KH; Paterson CC; Renard-Penna R; Ribal MJ; Roobol MJ; Rouprêt M; Rouvière O; Sancho Pardo G; Richenberg J; Schoots IG; Sedelaar JPM; Stricker P; Tilki D; Vahr Lauridsen S; van den Bergh RCN; Van den Broeck T; van der Kwast TH; van der Poel HG; van Leenders GJLH; Varma M; Violette PD; Wallis CJD; Wiegel T; Wilkinson K; Zattoni F; N'Dow JMO; Van Poppel H; Cornford P; Mottet N, 2019, 'EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)', European Urology, vol. 76, pp. 790 - 813, http://dx.doi.org/10.1016/j.eururo.2019.09.020

Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L, 2019, 'Diagnostic accuracy of 68Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of 68Ga-PSMA PET to mpMRI', BJU International, vol. 124, pp. 42 - 49, http://dx.doi.org/10.1111/bju.14794

Feng Y; Jaratlerdsiri W; Patrick SM; Lyons RJ; Haynes AM; Collins CC; Stricker PD; Bornman MSR; Hayes VM, 2019, 'Metagenomic analysis reveals a rich bacterial content in high-risk prostate tumors from African men', Prostate, vol. 79, pp. 1731 - 1738, http://dx.doi.org/10.1002/pros.23897

Quinn DI; Stricker PD; Kench JG; Grogan J; Haynes AM; Henshall SM; Grygiel JJ; Delprado W; Turner JJ; Horvath LG; Mahon KL, 2019, 'p53 nuclear accumulation as an early indicator of lethal prostate cancer', British Journal of Cancer, vol. 121, pp. 578 - 583, http://dx.doi.org/10.1038/s41416-019-0549-8

van Leeuwen PJ; Donswijk M; Nandurkar R; Stricker P; Ho B; Heijmink S; Wit EMK; Tillier C; van Muilenkom E; Nguyen Q; van der Poel HG; Emmett L, 2019, 'Gallium-68-prostate-specific membrane antigen (68Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer', BJU International, vol. 124, pp. 62 - 68, http://dx.doi.org/10.1111/bju.14506

Scheltema MJ; Chang JI; van den Bos W; Böhm M; Delprado W; Gielchinsky I; de Reijke TM; de la Rosette JJ; Siriwardana AR; Shnier R; Stricker PD, 2019, 'Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation', European Urology Focus, vol. 5, pp. 585 - 591, http://dx.doi.org/10.1016/j.euf.2017.10.007

Stricker PD; Van Leeuwen PJ, 2019, 'Editorial Comment', Journal of Urology, vol. 201, pp. 1142, http://dx.doi.org/10.1097/01.JU.0000554684.52942.bc

Zhang AY; Chiam K; Haupt Y; Fox S; Birch S; Tilley W; Butler LM; Knudsen K; Comstock C; Rasiah K; Grogan J; Mahon KL; Bianco-Miotto T; Ricciardelli C; Böhm M; Henshall S; Delprado W; Stricker P; Horvath LG; Kench JG, 2019, 'An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy', International Journal of Cancer, vol. 144, pp. 1151 - 1159, http://dx.doi.org/10.1002/ijc.31906

Thompson JE; Stricker PD, 2019, 'Editorial Comment', Journal of Urology, vol. 201, pp. 306 - 307, http://dx.doi.org/10.1097/01.JU.0000553007.26960.b9

Bancroft EK; Saya S; Page EC; Myhill K; Thomas S; Pope J; Chamberlain A; Hart R; Glover W; Cook J; Rosario DJ; Helfand BT; Selkirk CH; Davidson R; Longmuir M; Eccles DM; Gadea N; Brewer C; Barwell J; Salinas M; Greenhalgh L; Tischkowitz M; Henderson A; Evans DG; Buys SS; Eeles RA; Aaronson NK; Eeles R; Bancroft E; Page E; Kote-Jarai Z; Ardern-Jones A; Bangma C; Castro E; Dearnaley D; Falconer A; Foster C; Gronberg H; Hamdy FC; Johannsson OT; Khoo V; Eccles D; Lilja H; Evans G; Eyfjord J; Lubinski J; Maehle L; Mikropoulos C; Millner A; Mitra A; Offman J; Moynihan C; Rennert G; Suri M; Dias A; Taylor N; D'Mello L; Pope J; James P; Mitchell G; Shanley S; Richardson K; McKinley J; Petelin L; Murphy M; Mascarenhas L; Murphy D; Lam J; Taylor L; Miller C; Stapleton A; Chong M; Suthers G; Poplawski N; Tucker K; Andrews L; Duffy J; Millard R; Ward R; Williams R; Stricker P; Kirk J; Bowman M; Patel M; Harris M; O'Connell S; Hunt C; Smyth C; Frydenberg M; Lindeman G; Shackleton K; Morton C; Susman R; McGaughran J; Boon M; Pachter N; Townshend S; Schofield L; Nicholls C; Spigelman A; Gleeson M; Amor D; Burke J; Patterson B; Swindle P; Scott R; Foulkes W; Boshari T; Aprikian A; Jensen T; Bojeson A; Osther P; Skytte A-B; Cruger D; Tondering MK; Gerdes A-M; Schmutzler R; Rhiem K; Wihler P; Kast K; Griebsch C; Johannsson O; Stefansdottir V; Murthy V; Sarin R; Awatagiri K; Ghonge S; Kowtal P; Mulgund G; Gallagher D; Bambury R; Farrell M; Gallagher F; Kiernan I; Friedman E; Chen-Shtoyerman R; Basevitch A; Leibovici D; Melzer E; Ben-Yehoshua SJ; Nicolai N; Radice P; Valdagni R; Magnani T; Gay S; Teo SH; Tan HM; Yoon S-Y; Thong MK; Vasen H; Ringleberg J; van Asperen C; Kiemeney B; van Zelst-Stams W; Ausems MGEM; van der Luijt RB; van Os T; Ruijs MWG; Adank MA; Oldenburg RA; Helderman-van den Enden APTJM; Caanen BAH; Oosterwijk JC; Moller P; Brennhovd B; Medvik H; Hanslien E; Grindedal EM; Cybulski C; Wokolorczyk D; Teixeira M; Maia S; Peixoto A; Henrique R; Oliveira J; Goncalves N; Araujo L; Seixas M; Souto JP; Nogueira P; Copakova L; Zgajnar J; Krajc M; Vrecar A; Capella G; Ramon y Cajal T; Fisas D; Mora J; Esquena S; Balmana J; Morote J; Liljegren A; Hjalm-Eriksson M; Ekdahl K-J; Carlsson S; George A; Kemp Z; Wiggins J; Moss C; Van As N; Thompson A; Ogden C; Woodhouse C; Kumar P; Evans DG; Bulman B; Rothwell J; Tricker K; Wise G; Mercer C; McBride D; Costello P; Pearce A; Torokwa A; Paterson J; Clowes V; Taylor A; Newcombe B; Walker L; Halliday D; Stayner B; Fleming-Brown D; Snape K; Hanson H; Hodgson S; Brice G; Homfray T; Hammond C; Kohut K; Anjum U; Dearing A; Mencias M; Potter A; Renton C; Searle A; Hill K; Goodman S; Garcia L; Devlin G; Everest S; Nadolski M; Douglas F; Jobson I; Paez E; Donaldson A; Tomkins S; Langman C; Jacobs C; Pichert G; Shaw A; Kulkarni A; Tripathi V; Rose S; Compton C; Watson M; Reinholtz C; Brady A; Dorkins H; Melville A; Kosicka-Slawinska M; Cummings C; Kiesel V; Bartlett M; Randhawa K; Ellery N; Side L; Male A; Simon K; Rees K; Tidey L; Gurasashvili J; Nevitt L; Ingram S; Howell A; Rosario D; Catto J; Howson J; Ong K-R; Chapman C; Cole T; Heaton T; Hoffman J; Burgess L; Huber C; Islam F; Watt C; Duncan A; Kockelbergh R; Mzazi S; Dineen A; Sattar A; Kaemba B; Sidat Z; Patel N; Siguake K; Birt A; Poultney U; Umez-Eronini N; Mom J; Sutton V; Cornford P; Bermingham N; Yesildag P; Treherne K; Griffiths J; Cogley L; Gott H; Rubinstein WS; Hulick P; McGuire M; Shevrin D; Kaul K; Weissman S; Newlin A; Vogel K; Weiss S; Hook N; Buys S; Goldgar D; Conner T; Venne V; Stephenson R; Dechet C; Domchek S; Powers J; Rustgi N; Strom S; Arun B; Davis JW; Yamamura Y; Obeid E; Giri V; Gross L; Bealin L; Cooney K; Stoffel E; Okoth L, 2019, 'Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations', BJU INTERNATIONAL, vol. 123, pp. 284 - 292, http://dx.doi.org/10.1111/bju.14412

Emmett L; Crumbaker M; Ho B; Willowson K; Eu P; Ratnayake L; Epstein R; Blanksby A; Horvath L; Guminski A; Mahon K; Gedye C; Yin C; Stricker P; Joshua AM, 2019, 'Results of a Prospective Phase 2 Pilot Trial of 177 Lu–PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression', Clinical Genitourinary Cancer, vol. 17, pp. 15 - 22, http://dx.doi.org/10.1016/j.clgc.2018.09.014

Nandurkar R; Van Leeuwen P; Stricker P; Woo H; Kooner R; Yuen C; O'Neill G; Ende D; Cusick T; Ho B; Hickey A; Emmett L, 2019, '68Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery', British Journal of Radiology, vol. 92, pp. 20180667, http://dx.doi.org/10.1259/bjr.20180667

van Leeuwen PJ; Emmett L; Donswijk ML; Stricker PD; Pos FJ; Wit E; van der Poel HG, 2019, 'Early outcomes after [68Ga]PSMA-PET/CT guided salvage therapy in men with biochemical recurrence after radical prostatectomy', Tijdschrift voor Urologie, vol. 9, pp. 2 - 8, http://dx.doi.org/10.1007/s13629-018-00215-w

Emmett L; Yin C; Crumbaker M; Hruby G; Kneebone A; Epstein R; Nguyen Q; Hickey A; Ihsheish N; O'Neill G; Horvath L; Chalasani V; Stricker P; Joshua AM, 2019, 'Rapid modulation of PSMA expression by androgen deprivation: Serial 68Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen blockade', Journal of Nuclear Medicine, vol. 60, pp. 950 - 954, http://dx.doi.org/10.2967/jnumed.118.223099

Jaratlerdsiri W; Chan EKF; Gong T; Petersen DC; Kalsbeek AMF; Venter PA; Stricker PD; Riana Bornman MS; Hayes VM, 2018, 'Whole-genome sequencing reveals elevated tumor mutational burden and initiating driver mutations in African men with treatment-naïve, high-risk prostate cancer', Cancer Research, vol. 78, pp. 6736 - 6746, http://dx.doi.org/10.1158/0008-5472.CAN-18-0254

Gielchinsky I; Chang J; Cusick T; Delprado W; Nguyen Q; Yuen C; Savdie R; Böhm M; Haynes AM; Scheltema MJ; Stricker PD, 2018, 'Prostate cancer in 432 men aged <50 years in the prostate-specific antigen era: a new outlook', BJU International, vol. 122, pp. 35 - 41, http://dx.doi.org/10.1111/bju.14586

Scheltema MJ; Chang JI; Böhm M; van den Bos W; Blazevski A; Gielchinsky I; Kalsbeek AMF; van Leeuwen PJ; Nguyen TV; de Reijke TM; Siriwardana AR; Thompson JE; de la Rosette JJ; Stricker PD, 2018, 'Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy', World Journal of Urology, vol. 36, pp. 1383 - 1389, http://dx.doi.org/10.1007/s00345-018-2281-z

Algohary A; Viswanath S; Shiradkar R; Ghose S; Pahwa S; Moses D; Jambor I; Shnier R; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Purysko AS; Verma S; Ponsky L; Stricker P; Madabhushi A, 2018, 'Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings', Journal of Magnetic Resonance Imaging, vol. 48, pp. 818 - 828, http://dx.doi.org/10.1002/jmri.25983

Penzias G; Singanamalli A; Elliott R; Gollamudi J; Shih N; Feldman M; Stricker PD; Delprado W; Tiwari S; Böhm M; Haynes AM; Ponsky L; Fu P; Tiwari P; Viswanath S; Madabhushi A, 2018, 'Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findings', PLoS ONE, vol. 13, http://dx.doi.org/10.1371/journal.pone.0200730

Thompson JE; Stricker PD, 2018, 'MRI improves active surveillance of prostate cancer however biopsy is still crucial', BJU International, vol. 122, pp. E1 - E2, http://dx.doi.org/10.1111/bju.14424

Nair SS; Luu PL; Qu W; Maddugoda M; Huschtscha L; Reddel R; Chenevix-Trench G; Toso M; Kench JG; Horvath LG; Hayes VM; Stricker PD; Hughes TP; White DL; Rasko JEJ; Wong JJL; Clark SJ, 2018, 'Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten', Epigenetics and Chromatin, vol. 11, http://dx.doi.org/10.1186/s13072-018-0194-0

Pidsley R; Lawrence MG; Zotenko E; Niranjan B; Statham A; Song J; Chabanon RM; Qu W; Wang H; Richards M; Nair SS; Armstrong NJ; Nim HT; Papargiris M; Balanathan P; French H; Peters T; Norden S; Ryan A; Pedersen J; Kench J; Daly RJ; Horvath LG; Stricker P; Frydenberg M; Taylor RA; Stirzaker C; Risbridger GP; Clark SJ, 2018, 'Enduring epigenetic landmarks define the cancer microenvironment', Genome Research, vol. 28, pp. 625 - 638, http://dx.doi.org/10.1101/gr.229070.117

van den Bos W; Scheltema MJ; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD, 2018, 'Focal irreversible electroporation as primary treatment for localized prostate cancer', BJU International, vol. 121, pp. 716 - 724, http://dx.doi.org/10.1111/bju.13983

Thompson JE; Egger S; Böhm M; Siriwardana AR; Haynes AM; Matthews J; Scheltema MJ; Stricker PD, 2018, 'Superior Biochemical Recurrence and Long-term Quality-of-life Outcomes Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve—Updated Analysis of a Prospective Single-surgeon Cohort of 2206 Consecutive Cases', European Urology, vol. 73, pp. 664 - 671, http://dx.doi.org/10.1016/j.eururo.2017.11.035

Lin HM; Lee BY; Castillo L; Spielman C; Grogan J; Yeung NK; Kench JG; Stricker PD; Haynes AM; Centenera MM; Butler LM; Shreeve SM; Horvath LG; Daly RJ, 2018, 'Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancer', Prostate, vol. 78, pp. 308 - 317, http://dx.doi.org/10.1002/pros.23476

Kalsbeek AMF; Chan EKF; Grogan J; Petersen DC; Jaratlerdsiri W; Gupta R; Lyons RJ; Haynes AM; Horvath LG; Kench JG; Stricker PD; Hayes VM, 2018, 'Altered mitochondrial genome content signals worse pathology and prognosis in prostate cancer', Prostate, vol. 78, pp. 25 - 31, http://dx.doi.org/10.1002/pros.23440

Thompson J; Stricker P, 2018, 'Imaging: MRI improves cost and accuracy of prostate cancer biopsy', Nature Reviews Urology, vol. 15, pp. 6 - 8, http://dx.doi.org/10.1038/nrurol.2017.185

Gielchinsky I; Scheltema MJ; Cusick T; Chang J; Shnier R; Moses D; Delprado W; Nguyen Q; Yuen C; Haynes AM; Stricker PD, 2018, 'Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50', Research and Reports in Urology, vol. 10, pp. 145 - 150, http://dx.doi.org/10.2147/RRU.S169017

Roach PJ; Francis R; Emmett L; Hsiao E; Kneebone A; Hruby G; Eade T; Nguyen QA; Thompson BD; Cusick T; McCarthy M; Tang C; Ho B; Stricker PD; Scott AM, 2018, 'The impact of 68 Ga-PSMA PET/CT on management intent in prostate cancer: Results of an australian prospective multicenter study', Journal of Nuclear Medicine, vol. 59, pp. 82 - 88, http://dx.doi.org/10.2967/jnumed.117.197160

van Leeuwen PJ; Hayen A; Thompson JE; Moses D; Shnier R; Böhm M; Abuodha M; Haynes AM; Ting F; Barentsz J; Roobol M; Vass J; Rasiah K; Delprado W; Stricker PD, 2017, 'A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy', BJU International, vol. 120, pp. 774 - 781, http://dx.doi.org/10.1111/bju.13814

Emmett L; Van Leeuwen PJ; Nandurkar R; Scheltema MJ; Cusick T; Hruby G; Kneebone A; Eade T; Fogarty G; Jagavkar R; Nguyen Q; Ho B; Joshua AM; Stricker P, 2017, 'Treatment outcomes from 68Ga-PSMA PET/CT-informed salvage radiation treatment in men with rising PSA after radical prostatectomy: Prognostic value of a negative PSMA PET', Journal of Nuclear Medicine, vol. 58, pp. 1972 - 1976, http://dx.doi.org/10.2967/jnumed.117.196683

Scheltema MJ; van den Bos W; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD, 2017, 'Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer', BJU International, vol. 120, pp. 51 - 58, http://dx.doi.org/10.1111/bju.13991

Siriwardana A; Thompson J; van Leeuwen PJ; Doig S; Kalsbeek A; Emmett L; Delprado W; Wong D; Samaratunga H; Haynes AM; Coughlin G; Stricker P, 2017, 'Initial multicentre experience of 68gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited', BJU International, vol. 120, pp. 673 - 681, http://dx.doi.org/10.1111/bju.13919

Grogan J; Gupta R; Mahon KL; Stricker PD; Haynes AM; Delprado W; Turner J; Horvath LG; Kench JG, 2017, 'Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up', BJU International, vol. 120, pp. 651 - 658, http://dx.doi.org/10.1111/bju.13857


Back to profile page